Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+7.65%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$8.27B
AUM Growth
+$1.17B
(+17%)
Cap. Flow
+$750M
Cap. Flow
% of AUM
9.07%
Top 10 Holdings %
Top 10 Hldgs %
43.67%
Holding
1,071
New
101
Increased
574
Reduced
272
Closed
122
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$287M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
$258M |
| 3 |
Apple
AAPL
|
$67.9M |
| 4 |
Microsoft
MSFT
|
$62.7M |
| 5 |
iShares China Large-Cap ETF
FXI
|
$59.7M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$189M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$112M |
| 3 |
Visa
V
|
$56.8M |
| 4 |
Mastercard
MA
|
$50M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$42.1M |
Sector Composition
| 1 | Technology | 27.51% |
| 2 | Financials | 14.83% |
| 3 | Healthcare | 4.08% |
| 4 | Consumer Discretionary | 3.56% |
| 5 | Industrials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Paycom
PAYC
$12.6B
| $2.51M | 0.03% |
8,059
+1,519
| +23% | +$473K |
|
352
Linde
LIN
$220B
| $2.51M | 0.03% |
10,520
+9,125
| +654% | +$2.17M |
|
353
Norfolk Southern
NSC
$62.3B
| $2.5M | 0.03% |
11,687
-501
| -4% | -$107K |
|
354
Assurant
AIZ
$10.7B
| $2.5M | 0.03% |
20,582
+8,276
| +67% | +$1M |
|
|
Y
355
DELISTED
Alleghany Corporation
Y
| $2.5M | 0.03% |
4,795
+1,925
| +67% | +$1M |
|
|
MRTX
356
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.49M | 0.03% |
15,021
+5,700
| +61% | +$946K |
|
357
Cullen/Frost Bankers
CFR
$8.24B
| $2.48M | 0.03% |
38,804
+6,888
| +22% | +$441K |
|
|
XLRN
358
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.47M | 0.03% |
21,949
+11,942
| +119% | +$1.34M |
|
359
Equinix
EQIX
$75.7B
| $2.45M | 0.03% |
3,228
-17,953
| -85% | -$13.6M |
|
360
Opko Health
OPK
$1.07B
| $2.45M | 0.03% |
663,597
+278,500
| +72% | +$1.03M |
|
361
NextEra Energy, Inc.
NEE
$146B
| $2.45M | 0.03% |
35,236
-15,936
| -31% | -$1.11M |
|
362
Twist Bioscience
TWST
$1.55B
| $2.41M | 0.03% |
31,742
+14,113
| +80% | +$1.07M |
|
363
Natera
NTRA
$23.1B
| $2.41M | 0.03% |
33,287
+9,963
| +43% | +$720K |
|
364
Crown Castle
CCI
$41.9B
| $2.39M | 0.03% |
14,339
-85,088
| -86% | -$14.2M |
|
365
Curtiss-Wright
CW
$18.1B
| $2.37M | 0.03% |
25,446
+2,361
| +10% | +$220K |
|
366
Coterra Energy
CTRA
$18.3B
| $2.37M | 0.03% |
136,275
-14,182
| -9% | -$246K |
|
367
Fate Therapeutics
FATE
$116M
| $2.36M | 0.03% |
59,123
+28,058
| +90% | +$1.12M |
|
368
Alnylam Pharmaceuticals
ALNY
$59.2B
| $2.36M | 0.03% |
16,206
+6,263
| +63% | +$912K |
|
369
Synovus
SNV
$7.15B
| $2.35M | 0.03% |
111,045
+14,049
| +14% | +$297K |
|
|
ARNA
370
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.34M | 0.03% |
31,310
+15,733
| +101% | +$1.18M |
|
371
Champion Homes, Inc.
SKY
$4.43B
| $2.33M | 0.03% |
87,161
+16,434
| +23% | +$440K |
|
372
Simpson Manufacturing
SSD
$8.15B
| $2.32M | 0.03% |
23,895
+3,234
| +16% | +$314K |
|
373
Allogene Therapeutics
ALLO
$255M
| $2.31M | 0.03% |
61,277
+38,428
| +168% | +$1.45M |
|
374
Inovio Pharmaceuticals
INO
$148M
| $2.28M | 0.03% |
16,404
+10,292
| +168% | +$1.43M |
|
|
CCXI
375
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.26M | 0.03% |
41,275
+26,605
| +181% | +$1.46M |
|